Hero image with Pittsburgh background pittplusme.org/study/1451

STUDY BASICS

Are you a healthy adult female who has delivered at least one child? If so, you may be eligible to participate in a research study to help develop a new immunotherapy. Participants will provide a saliva sample and may be asked to provide a blood sample. Your child or the father of your child will also be asked to provide a saliva sample. Compensation provided.


STUDY PURPOSE

Immunotherapy is a type of therapy that works by stimulating or suppressing the body’s immune system. Immunotherapy treatments are commonly used to treat cancer, allergies, infections, and autoimmune diseases, and can also be used to help people undergoing transplants.

The purpose of this study is to help researchers collect immune cells in order to develop a new immunotherapy treatment. Researchers hope their findings will lead to better treatments for people with cancer and other health conditions in the future.  


COULD THIS STUDY BE RIGHT FOR YOU?
  • Healthy females ages 18 and up
  • Delivered at least one child
  • No history of autoimmune diseases or disorders
  • Have never had a stem cell or organ transplant
  • Have not recently used steroids
  • The child, or the father of the child, is willing to provide a saliva sample 

WHAT PARTICIPANTS CAN EXPECT

Participation involves 1 or 2 visits. During the first visit, participants will complete a questionnaire and provide a saliva sample. If the DNA from your saliva shows that you have certain types of immune cells in your body, you will be asked to return for a second visit.

During the second visit, participants will be asked to provide a blood sample. Your child or the father of your child will also be asked to provide a saliva sample but they do not need to come in for a visit. The study team can provide an at-home saliva collection kit that can be returned by mail.


IRB:
  STUDY18110025 - Collection of Biospecimens from Healthy Parous Women and Her Child or a Father of Her Child, or Donor-Recipient Pairs of Allogeneic Stem Cell Transplantation for Development of Minor Histocompatibility Antigen- and Leukemia-specific T cells.


Age Range
AGE:   18 and up

 
Gender List
SEX ASSIGNED AT BIRTH:   Female

Duration VISITS:  Up to 2 visits

Location LOCATION: 
UPMC Hillman Cancer Center
Compensation COMPENSATION: 

Up to $45

Phone Number PHONE NUMBER:
1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In
Search Icon pittplusme.org/study/1451
OR
Phone Number PHONE NUMBER:
1-866-438-8230

MEET THE RESEARCHER


Sawa Ito

Sawa Ito, MD, PhD, is an Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Pittsburgh. A graduate of Hokkaido University School of Medicine in Sapporo, Japan, Dr. Ito’s research interests include finding ways to harness the graft-versus-leukemia immune effect to cure leukemia and lymphoma.




PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet